72917-37-4

Basic information

• Product Name: 2,5-DiMethyl-4-aMinobenzonitrile
• Synonyms: 2,5-DiMethyl-4-aMinobenzonitrile;4-Amino-2,5-dimethylbenzonitrile
• CAS NO: 72917-37-4
• Molecular Formula: C₉H₁₀N₂
• Molecular Weight: 146.1891
• Mol File: 72917-37-4.mol

Chemical Properties

• Melting Point: 158-160 °C(Solv: benzene (71-43-2))
• Boiling Point: 315.9±30.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• PKA: 1.70±0.10(Predicted)
• CAS DataBase Reference: 2,5-DiMethyl-4-aMinobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-DiMethyl-4-aMinobenzonitrile(72917-37-4)
• EPA Substance Registry System: 2,5-DiMethyl-4-aMinobenzonitrile(72917-37-4)

Safety Data

• Hazardous Substances Data: 72917-37-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,5-Dimethyl-4-aminobenzonitrile is used as a key intermediate for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Dye Industry:
2,5-DiMethyl-4-aMinobenzonitrile is utilized as an intermediate in the production of dyes, playing a crucial role in the coloration and enhancement of various materials.
Used in Plastics and Polymer Industry:
2,5-Dimethyl-4-aminobenzonitrile is used as a raw material for the production of UV stabilizers for plastics and polymers, helping to protect these materials from degradation caused by exposure to ultraviolet radiation.
Used in Organic Synthesis:
As a building block in organic synthesis, 2,5-Dimethyl-4-aminobenzonitrile is used for the synthesis of 1,2,4-triazole derivatives, which have applications in medicine and agriculture, contributing to the development of new treatments and products in these fields.
Used in Material Development:
2,5-Dimethyl-4-aminobenzonitrile may have potential applications in the development of new materials, showcasing its versatility and importance in various industries.
It is important to handle 2,5-Dimethyl-4-aminobenzonitrile with care, as it may be hazardous if not handled properly.

Upstream product

• 557-21-1 zinc(II) cyanide 
• 30273-40-6 4-bromo-2,5-dimethylaniline 
• 73713-69-6 2,5-Dimethyl-4-nitrobenzonitrile 
• 13711-31-4 N-(4-bromo-2,5-dimethyl-phenyl)acetamide 
• 544-92-3 copper(I) cyanide 

Downstream Products

• 259537-71-8 6-Methyl-1 H-indazole-5-carbonitrile 
• 1613730-45-2 4-amino-3-iodo-2, 5-dimethylbenzonitrile 
• 1613730-46-3 4-amino-2,5-dimethyl-3-((trimethylsilyl)ethynyl)benzonitrile 
• 72917-42-1 4-Hydroxy-2',5'-dimethyl-4'-cyanodiphenylamine 
• 72917-36-3 1,4-Dimethyl-3-cyano-6-hydroxycarbazole 
• 72917-44-3 5,11-Dihydro-2,8-dicyano-1,4,7,10-tetramethylindolo<3,2-b>carbazole 
• 72917-40-9 1,4-Dihydroxy-2,5-bis(2-amino-3,6-dimethyl-5-cyanophenyl)benzene 

Relevant articles and documents

FUNGICIDAL ARYL AMIDINES

This disclosure relates to aryl amidines of Formula I and their use as fungicides. One embodiment of the present disclosure is a use of a compound of Formula I, for protection of a plant against attack by a phytopathogenic organism or the treatment of a plant infested by a phytopathogenic organism, comprising the application of a compound of Formula I, or a composition comprising the compound to soil, a plant, a part of a plant, foliage, and/or roots.

INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

The invention relates to indole carboxamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.

Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents

This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.

ANTITHROMBOTIC AGENTS

Compounds of formula (I): Are antithrombotic agents, having utility in a variety of therapeutic areas including the prevention and/or treatment of deep vein thrombosis (DVT) after surgery, major medical illness, paralysis, malignancy, prolonged immobilisa

Antithrombotic agents

Compounds of formula (I) : are antithrombotic agents, having utility in a variety of therapeutic areas including the prevention and/or treatment of deep vein thrombosis (DVT) after surgery, major medical illness, paralysis, malignancy, prolonged immobilis